Zobrazeno 1 - 10
of 1 198
pro vyhledávání: '"Afd Pharmacoepi & Clinical Pharmacology"'
Autor:
Samukange, Washington T, Lu, Ting-An, Souverein, Patrick C, Gardarsdottir, Helga, Mantel-Teeuwisse, Aukje K, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology
Publikováno v:
Transfusion, 63(5), 982. Wiley-Blackwell
INTRODUCTION: Since being designated as medicines by World Health Organization (WHO), blood components are subject to pharmacovigilance reporting. Using VigiBase, the WHO global database of individual case safety reports (ICSRs), we characterized rep
Autor:
Hogervorst, Milou A, Vreman, Rick A, Zawada, Anna, Zielińska, Magdalena, Dawoud, Dalia M, de Jong, Brigit A, Mantel-Teeuwisse, Aukje K, Goettsch, Wim G, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology
Publikováno v:
Clinical and Translational Science. Wiley-Blackwell
Clinical and Translational Science, 16(5), 835. Wiley-Blackwell Publishing Ltd
Hogervorst, M A, Vreman, R A, Zawada, A, Zielińska, M, Dawoud, D M, de Jong, B A, Mantel-Teeuwisse, A K & Goettsch, W G 2023, ' Synergy between health technology assessments and clinical guidelines for multiple sclerosis ', Clinical and Translational Science . https://doi.org/10.1111/cts.13492
Clinical and Translational Science, 16(5), 835. Wiley-Blackwell Publishing Ltd
Hogervorst, M A, Vreman, R A, Zawada, A, Zielińska, M, Dawoud, D M, de Jong, B A, Mantel-Teeuwisse, A K & Goettsch, W G 2023, ' Synergy between health technology assessments and clinical guidelines for multiple sclerosis ', Clinical and Translational Science . https://doi.org/10.1111/cts.13492
Decision-making for reimbursement and clinical guidelines (CGs) serves different purposes although the decision-criteria and required evidence largely overlap. This study aimed to assess similarities and discrepancies between health technology assess
Autor:
Gemmeke, Marle, Koster, Ellen, van der Velde, Nathalie, Taxis, Katja, Bouvy, Marcel, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology
Publikováno v:
Research in Social and Administrative Pharmacy, 19(1), 155. Elsevier
Background: Community pharmacists are in the position to contribute to fall prevention, but this is not yet common practice. Objective: The aim of this study was to evaluate the implementation of a community pharmacy-based fall prevention service. Me
Autor:
Kranendonk, J, Willems, L H, Vijver-Coppen, Rj van der, Coenen, M, Adang, E, Donders, R, Zeebregts, C J, Deneer, V, Reijnen, Mmpj, Kramers, C, Warlé, M C, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
American heart journal, 254, 141-148. Mosby Inc.
American Heart Journal, 254, 141. Mosby Inc.
American Heart Journal, 254, 141-148
American Heart Journal, 254, 141-148. MOSBY-ELSEVIER
American Heart Journal, 254, pp. 141-148
American Heart Journal, 254, 141. Mosby Inc.
American Heart Journal, 254, 141-148
American Heart Journal, 254, 141-148. MOSBY-ELSEVIER
American Heart Journal, 254, pp. 141-148
Background: Clopidogrel is recommended in international guidelines to prevent arterial thrombotic events in patients with peripheral arterial disease (PAD). Clopidogrel itself is inactive and metabolism is dependent on the CYP2C19 enzyme. About 30% o
Autor:
Hino, Yoshitsugu, Okada, Miu, Hallgreen, Christine Erikstrup, De Bruin, Marie Louise, Doty, Randell E, Matsumaru, Naoki, Tsukamoto, Katsura, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Biological and Pharmaceutical Bulletin, 46(5), 700. Pharmaceutical Society of Japan
A cancer diagnosis is devastating for both patients and their caregivers. With high morbidity and mortality, cancer is a serious disease area with unmet medical needs. Thus, innovative anticancer drugs are in high demand worldwide but are unequally a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57449fb52f5d124df4b06c960cbed93
https://dspace.library.uu.nl/handle/1874/428433
https://dspace.library.uu.nl/handle/1874/428433
Autor:
Kempen, Thomas G. H., Hedman, Anton N., Hadziosmanovic, Nermin, Lindner, Karl‐Johan, Melhus, Håkan, Nielsen, Elisabet I., Sulku, Johanna, Gillespie, Ulrika, Afd Pharmacoepi & Clinical Pharmacology
Publikováno v:
British Journal of Clinical Pharmacology, 89(5), 1575. NLM (Medline)
Aim: To identify older patients’ risk factors for drug-related readmissions and assess the preventability of older patients’ drug-related revisits. Methods: Post-hoc analysis of a randomised clinical trial with patients aged ≥ 65 years at eight
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa815eb2d733c41d3b9dcc99a2b10f3a
https://dspace.library.uu.nl/handle/1874/427958
https://dspace.library.uu.nl/handle/1874/427958
Autor:
Leung, Melissa Wy, Bazelier, Marloes T, Souverein, Patrick C, Uitdehaag, Bernard Mj, Klungel, Olaf H, Leufkens, Hubert Gm, Pajouheshnia, Romin, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Leung, M W Y, Bazelier, M T, Souverein, P C, Uitdehaag, B M J, Klungel, O H, Leufkens, H G M & Pajouheshnia, R 2022, ' Mapping the risk of infections in patients with multiple sclerosis : A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum ', Multiple Sclerosis Journal, vol. 28, no. 11, pp. 1808-1818 . https://doi.org/10.1177/13524585221094218
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors include underlying disease, physical impairment and use of some disease-modifying treatments. Objective: To quantify changes in population-level infe
Autor:
Al Khayat, Mohamed N M T, Eijsink, Job F H, Postma, Maarten J, van de Garde, Ewoudt M W, van Hulst, Marinus, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Journal of Health Economics, 23(7), 1221. Springer Verlag
European Journal of Health Economics, 23(7), 1221-1227. Springer Verlag
European Journal of Health Economics, 23(7), 1221-1227. Springer Verlag
Objective We aimed to assess the cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands. Methods A Markov model was used to evaluate the health effects and costs of lung cancer screening from the healthcare perspect
Autor:
Huibers, C J A, Sallevelt, B T G M, Heij, J M J Op, O'Mahony, D, Rodondi, N, Dalleur, O, van Marum, R J, Egberts, A C G, Wilting, I, Knol, W, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Geriatric Medicine, 13(3), 541-552. Elsevier Masson
European Geriatric Medicine, 13(3), 541. Elsevier Masson SAS
European Geriatric Medicine, (2022)
Huibers, C J A, Sallevelt, B T G M, Heij, J M J O, O’Mahony, D, Rodondi, N, Dalleur, O, van Marum, R J, Egberts, A C G, Wilting, I & Knol, W 2022, ' Hospital physicians’ and older patients’ agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting ', European Geriatric Medicine, vol. 13, no. 3, pp. 541-552 . https://doi.org/10.1007/s41999-022-00633-5
Huibers, C J A; Sallevelt, B T G M; Heij, J M J Op; O'Mahony, D; Rodondi, N; Dalleur, O; van Marum, R J; Egberts, A C G; Wilting, I; Knol, W (2022). Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting. European geriatric medicine, 13(3), pp. 541-552. Elsevier 10.1007/s41999-022-00633-5
European Geriatric Medicine, 13(3), 541. Elsevier Masson SAS
European Geriatric Medicine, (2022)
Huibers, C J A, Sallevelt, B T G M, Heij, J M J O, O’Mahony, D, Rodondi, N, Dalleur, O, van Marum, R J, Egberts, A C G, Wilting, I & Knol, W 2022, ' Hospital physicians’ and older patients’ agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting ', European Geriatric Medicine, vol. 13, no. 3, pp. 541-552 . https://doi.org/10.1007/s41999-022-00633-5
Huibers, C J A; Sallevelt, B T G M; Heij, J M J Op; O'Mahony, D; Rodondi, N; Dalleur, O; van Marum, R J; Egberts, A C G; Wilting, I; Knol, W (2022). Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting. European geriatric medicine, 13(3), pp. 541-552. Elsevier 10.1007/s41999-022-00633-5
Objective To evaluate the agreement of hospital physicians and older patients with individualised STOPP/START-based medication optimisation recommendations from a pharmacotherapy team. Methods This study was embedded within a large European, multicen
Autor:
Noorda, Nikki M.F., Sallevelt, Bastiaan T.G.M., Langendijk, Wivien L., Egberts, Toine C.G., van Puijenbroek, Eugène P., Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Geriatric Medicine, 13(4), 837. Elsevier Masson SAS
European Geriatric Medicine, 13. Springer
European Geriatric Medicine, 13. Springer
Key summary pointsAim To investigate the performance of an adverse drug reaction (ADR) trigger tool in patients with polypharmacy acutely admitted to our geriatric ward. Findings The ADR trigger tool had a positive predictive value (PPV) of 41.8%. Us